Knee osteoarthritis(Arthrosis). Chapter XIII Diseases of the musculoskeletal system and connective tissue(M00-M99)
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: aged 38-74 years pain at least for 3 months No use of pain killer or anti inflammation drugs both sexes with knee osteoarthritis in stages 2 and 3
Exclusion criteria
Exclusion criteria: neuropathic disorder nerve(sensory and motor) injury auto immune diseases any metallic implant in the joint structural giving way contraindications for electrotherapy ( for example cardiac patients with pacemaker) Malignancies Epilepsy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain score in the questionnaire. Timepoint: Before starting the intervention and after 10 sessions of treatment. Method of measurement: Knee Osteoarthritis Outcome Score (KOOS) questionnaire.;Symptoms score in the questionnaire. Timepoint: Before starting the intervention and after 10 sessions of treatment. Method of measurement: Knee Osteoarthritis Outcome Score (KOOS)questionnaire.;ADL(Activity Daily Living) score in the questionnaire. Timepoint: Before starting the intervention and after 10 sessions of treatment. Method of measurement: Knee Osteoarthritis Outcome Score (KOOS) questionnaire.;Sports / recreational activity score in the questionnaire. Timepoint: Before starting the intervention and after 10 sessions of treatment. Method of measurement: Knee Osteoarthritis Outcome Score (KOOS) questionnaire.;Quality of life score in the questionnaire. Timepoint: Before starting the intervention and after 10 sessions of treatment. Method of measurement: Knee Osteoarthritis Outcome Score (KOOS) questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Shahid Beheshti University of Medical Sciences